This Item 4 of the Schedule 13D is amended and supplemented as follows: As disclosed by the Issuer, on March 30, 2026, the Issuer announced the issuance of registered ordinary shares for an aggregate of $50 million, issued under the Issuer's "at the market" share issuance program pursuant to the open market sale agreement, dated September 5, 2025, as amended, between the Issuer and Jefferies LLC (the "Capital Raise"). As a result of the Capital Raise, the Reporting Persons' beneficial ownership decreased by more than 1% of the Issuer's outstanding equity securities. Additionally, on March 30, 2026, MCM agreed in principle, subject to further negotiation and the execution of definitive agreements, to: (i) amend the existing 10.00% / 12.00% Convertible Senior Secured Notes held by certain of the Reporting Persons to extend their maturity from December 2028 to December 2030; and (ii) provide a facility under which it would purchase up to $50 million of new additional convertible secured notes subject to certain conditions, issuable in tranches over 12 months, and on the same terms as the existing notes. The Reporting Persons previously acquired Issuer Securities for investment purposes. The Reporting Persons review their investment in the Issuer on a continuing basis and consider such other factors relevant to the Reporting Persons, which could include the price and availability of Issuer Securities, the Issuer's business and the Issuer's prospects, applicable legal restrictions, prevailing market conditions, other investment opportunities, tax considerations, liquidity requirements of such Reporting Person and/or other investment considerations. Without limiting the generality of the preceding sentence, each of the Reporting Persons (in each case, subject to any applicable restrictions under applicable law) may at any time or from time to time: (i) purchase, receive in a distribution or other transfer, or otherwise acquire Issuer Securities (including, but not limited to up to $50 million of new additional convertible secured notes as discussed above), in public or private transactions; (ii) convert or redeem all or a portion of the Convertible Senior Secured Notes for Ordinary Shares; (iii) exercise all or a portion of the Existing Warrants, Tranche A Warrants and/or Tranche B Warrants, in each case, for Ordinary Shares; (iv) sell, transfer, distribute or otherwise dispose of all or a portion of its Issuer Securities in public or private transactions, including in registered offerings, subject to any applicable lock-up or other agreement; (v) enter into derivatives or hedging transactions relating to Issuer Securities and/or (vi) enter into agreements with a broker intended to comply with the requirements of Rule 10b5-1(c)(1)(i) under the Act, on such terms and at such time as the Reporting Persons may deem advisable. Subject to the agreements described in the Schedule 13D, the Reporting Persons, at any time and from time to time, may review, reconsider and change their position and/or change their purpose and/or develop such plans, including with respect to influence on management or the Board regarding the business and affairs of the Issuer, including with respect to MCM's consent rights with respect to the Issuer's governance documents and the Board's composition as disclosed in Amendment No. 3, and engage with advisors, the Issuer or other persons regarding such matters.